Charles Morgan Kendrick Jr. - 01 Mar 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & President, Commercial
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2024
Net transactions value: -$740,679
Form type: 4
Filing time: 05 Mar 2024, 16:27:07 UTC
Previous filing: 03 Nov 2023
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$740,679	-1,484	-9.7%	$499.11	13,764	01 Mar 2024	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2,154	+16%	$0.000000	15,918	01 Mar 2024	Direct	F2
transaction	ELV	Common Stock	Award	$0	+2,354	+15%	$0.000000	18,272	01 Mar 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+8,312		$0.000000	8,312	01 Mar 2024	Common Stock	8,312	$499.11	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows:718 shares on 3/1/2025, 3/1/2026, and 3/1/2027.
F3	Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
F4	The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.